Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
Actual shortage: | 251 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-07-23 | 2020-08-21 | 120899 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2021-07-15 | 2021-09-02 | 142619 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2022-09-30 | 2022-12-22 | 170792 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-01-19 | 2023-06-09 | 181599 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-01-19 | 2023-04-28 | 181605 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183413 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-06-08 | 2023-10-19 | 194154 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-06-16 | 2023-07-28 | 195115 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195557 |
TEVA-CANDESARTAN | 8MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211985 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2024-01-25 | 2024-02-08 | 217237 |
TEVA-CANDESARTAN | 16MG | TABLET | Actual shortage | 2024-02-22 | 2024-04-05 | 220267 |
TEVA-CANDESARTAN | 32MG | TABLET | Actual shortage | 2024-03-28 | 2024-04-05 | 223853 |
TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 974 |
TEVA-CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2019-06-18 | 2020-04-23 | 86963 |
TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2019-11-28 | 2020-04-23 | 99932 |
TEVA-CANDESARTAN/HCTZ | 32MG 12.5MG | TABLET | Resolved | 2020-07-23 | 2020-08-21 | 120878 |
TEVA-CANDESARTAN/HCTZ | 32MG 12.5MG | TABLET | Resolved | 2021-01-28 | 2021-03-04 | 132657 |
TEVA-CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2021-10-21 | 2022-01-07 | 147702 |
TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2022-10-28 | 2022-12-15 | 173031 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |